| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
| filingDate |
2004-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2821290090442727508d1c7b115ca17f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e828ab65d36a64643f547d67bd68832 |
| publicationDate |
2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004171672-A1 |
| titleOfInvention |
Synthetic salicylihalamides, apicularens and derivatives thereof |
| abstract |
The present invention provides compounds having improved stability over that of natural benzolactones, and a process for synthesizing these compounds. These compounds exhibit anti-cancer activity and inhibit V-ATPase activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8013157-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008079255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324292-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LU-91725-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012028732-A1 |
| priorityDate |
2000-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |